Published in Pediatr Radiol on July 01, 1998
Cytotoxic T cells and immunotherapy. Pediatr Radiol (1998) 0.75
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood (1998) 6.26
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
Jak2 is essential for signaling through a variety of cytokine receptors. Cell (1998) 5.92
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Tumor spectrum in ARF-deficient mice. Cancer Res (1999) 3.11
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia (2010) 2.22
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood (2001) 2.20
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood (1998) 1.86
Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol (1991) 1.82
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother (1995) 1.71
The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol (1998) 1.65
Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet (1993) 1.53
Donor T cells to treat EBV-associated lymphoma. N Engl J Med (1994) 1.53
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Remote congenital cerebral arteriovenous fistulae associated with aortic coarctation. Case report. J Neurosurg (1992) 1.47
Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant (1999) 1.46
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood (1994) 1.45
Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther (2001) 1.42
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene (1992) 1.41
Multiple epiphyseal dysplasia misdiagnosed as bioinactive growth hormone disorder. South Med J (1991) 1.40
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood (2000) 1.37
Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer (2000) 1.37
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet (1997) 1.25
Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol (1995) 1.19
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant (2005) 1.19
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther (1994) 1.14
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML). Bone Marrow Transplant (2006) 1.10
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia (2012) 1.10
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer (2001) 1.08
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation (2001) 1.08
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology (2008) 1.06
Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant (2007) 1.05
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia (2001) 1.05
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma. Int J Cancer (2001) 1.04
Brain metastases in children with melanoma. Cancer (1997) 1.03
Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer (1997) 1.02
Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.01
Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum Gene Ther (2004) 0.99
Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.98
Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia (1995) 0.97
Late vascular occlusion of central lines in pediatric malignancies. Pediatrics (1998) 0.97
Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther (1998) 0.96
The immunogenicity of virus-derived 2A sequences in immunocompetent individuals. Gene Ther (2013) 0.96
Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.96
T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Ann N Y Acad Sci (2005) 0.96
Requirements for the adoptive transfer of antibody responses to a priming antigen in man. J Immunol (1990) 0.96
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Blood (2001) 0.94
Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer (2014) 0.94
Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma. Cancer (2001) 0.94
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine. Leukemia (2010) 0.93
Ultrasonic characterization of human cancellous bone in vitro using three different apparent backscatter parameters in the frequency range 0.6-15.0 mhz. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 0.93
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood (1989) 0.92
Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences. Cytotherapy (2008) 0.92
Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Bone Marrow Transplant (1999) 0.91
Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis (1993) 0.91
Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines. Curr Top Microbiol Immunol (2001) 0.90
Reversal of optic canal stenosis in osteopetrosis after bone marrow transplant. Am J Ophthalmol (2000) 0.90
Clear cell sarcoma of soft tissues in children and young adults: the St. Jude Children's Research Hospital experience. Pediatr Hematol Oncol (2000) 0.89
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant (2003) 0.89
Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Med Pediatr Oncol (1997) 0.89
A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer (1989) 0.88
Splenic rupture in children with hematologic malignancies. Cancer (2000) 0.88
Immunotherapy for Hodgkin's disease. Ann Hematol (2002) 0.88
Current status of genetic modification of T cells for cancer treatment. Cytotherapy (2005) 0.88
Is retroviral gene marking too dangerous to use? Cytotherapy (2003) 0.87
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transplant (2005) 0.87
Use of chest computed tomography in the staging of pediatric Wilms' tumor: interobserver variability and prognostic significance. J Clin Oncol (1997) 0.87
Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health. J Bone Miner Res (1999) 0.86
Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy. Blood (1989) 0.86
Energy expenditure in children undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.86
Immunotherapy for Epstein-Barr virus-associated cancers. J Natl Cancer Inst Monogr (1998) 0.86
Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT. Bone Marrow Transplant (2010) 0.86
Ultrasonic characterization of cancellous bone using apparent integrated backscatter. Phys Med Biol (2006) 0.85
Hemangiopericytoma in children and infants. Cancer (2000) 0.85
Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant (1994) 0.84
Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity. Mol Med Today (1997) 0.84
Human gene marker/therapy clinical protocols. Hum Gene Ther (2000) 0.84
Hodgkin disease: use of Tl-201 to monitor mediastinal involvement after treatment. Radiology (1998) 0.83
Metastatic osteosarcoma to the liver after treatment for synovial sarcoma: a case report. Pediatr Hematol Oncol (2001) 0.83
Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution. Leuk Lymphoma (2010) 0.83
Disseminated intrathoracic desmoplastic small round-cell tumor: a case report. J Pediatr Hematol Oncol (1997) 0.83
Gene marking and autologous bone marrow transplantation. Ann N Y Acad Sci (1994) 0.83
The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol (2010) 0.82
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells. Blood (1991) 0.82
How does osteonecrosis about the knee progress in young patients with leukemia?: a 2- to 7-year study. Clin Orthop Relat Res (2010) 0.82
Soft tissue sarcoma of the hand in children: clinical outcome and management. J Pediatr Surg (1997) 0.82
Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant (2011) 0.82
CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors. Bone Marrow Transplant (2005) 0.82
Adoptive immunotherapy for Epstein-Barr virus-related lymphoma. Leuk Lymphoma (1996) 0.82
Dental abnormalities in children preparing for pediatric bone marrow transplantation. Bone Marrow Transplant (2005) 0.81
Effect of collagen and mineral content on the high-frequency ultrasonic properties of human cancellous bone. Osteoporos Int (2002) 0.81
Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site. Cancer (1997) 0.80
Dental abnormalities after pediatric bone marrow transplantation. Bone Marrow Transplant (2005) 0.80
Fractures in children treated with radiotherapy for soft tissue sarcoma. Orthopedics (1996) 0.80
Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. J Immunol (1989) 0.80
Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation. Bone Marrow Transplant (2001) 0.79